• Home

  • Documents

  • COMPARABILITY CHALLENGES FOR ALLOGENEIC CELL THERAPY ...€¦ · COMPARABILITY CHALLENGES FOR...
12
COMPARABILITY CHALLENGES FOR ALLOGENEIC CELL THERAPY PRODUCTS Ángel Herrero, PhD The seventh annual regulatory conference organised by EBE, 4 December 2018, London Session 3: Complexity of innovative manufacturing and the associated challenges for comparability

COMPARABILITY CHALLENGES FOR ALLOGENEIC CELL THERAPY ...€¦ · COMPARABILITY CHALLENGES FOR ALLOGENEIC CELL THERAPY PRODUCTS ÁngelHerrero, PhD The seventh annual regulatory conference

  • Upload
    others

  • View
    2

  • Download
    0

Embed Size (px)

Citation preview

Page 1: COMPARABILITY CHALLENGES FOR ALLOGENEIC CELL THERAPY ...€¦ · COMPARABILITY CHALLENGES FOR ALLOGENEIC CELL THERAPY PRODUCTS ÁngelHerrero, PhD The seventh annual regulatory conference

COMPARABILITYCHALLENGESFORALLOGENEICCELLTHERAPYPRODUCTS

Ángel Herrero,PhD

TheseventhannualregulatoryconferenceorganisedbyEBE,4December2018,LondonSession3:Complexityofinnovativemanufacturingandtheassociatedchallengesforcomparability

Page 2: COMPARABILITY CHALLENGES FOR ALLOGENEIC CELL THERAPY ...€¦ · COMPARABILITY CHALLENGES FOR ALLOGENEIC CELL THERAPY PRODUCTS ÁngelHerrero, PhD The seventh annual regulatory conference

COMPARABILITYCHALLENGESFORALLOGENEICCELLTHERAPYPRODUCTS

ALOFISEL

Page 3: COMPARABILITY CHALLENGES FOR ALLOGENEIC CELL THERAPY ...€¦ · COMPARABILITY CHALLENGES FOR ALLOGENEIC CELL THERAPY PRODUCTS ÁngelHerrero, PhD The seventh annual regulatory conference

COMPARABILITYCHALLENGESFORALLOGENEICCELLTHERAPYPRODUCTS

§ Newrawmaterials:Startingmaterials

§ ChangesintheManufacturingprocess

§ Scale-up

§ Transfers

§ …

§ Changesintheanalyticalmethods

Evolvingfield

WHENCOMPARABILITYSTUDIESARENEEDED?

Page 4: COMPARABILITY CHALLENGES FOR ALLOGENEIC CELL THERAPY ...€¦ · COMPARABILITY CHALLENGES FOR ALLOGENEIC CELL THERAPY PRODUCTS ÁngelHerrero, PhD The seventh annual regulatory conference

COMPARABILITYCHALLENGESFORALLOGENEICCELLTHERAPYPRODUCTS

§ Newrawmaterials:Mediaofknowncomposition

§ ChangesintheManufacturingprocess:Bioreactors

§ Changesintheanalyticalmethods:Nextgenerationsequencing

WHENCOMPARABILITYSTUDIESARENEEDED?

Page 5: COMPARABILITY CHALLENGES FOR ALLOGENEIC CELL THERAPY ...€¦ · COMPARABILITY CHALLENGES FOR ALLOGENEIC CELL THERAPY PRODUCTS ÁngelHerrero, PhD The seventh annual regulatory conference

COMPARABILITYCHALLENGESFORALLOGENEICCELLTHERAPYPRODUCTS

RISKASSESSMENT

CHANGEIDENTIFIED

ACTIONPLANFORIMPLEMENTATION

COMPARABILITY………

Page 6: COMPARABILITY CHALLENGES FOR ALLOGENEIC CELL THERAPY ...€¦ · COMPARABILITY CHALLENGES FOR ALLOGENEIC CELL THERAPY PRODUCTS ÁngelHerrero, PhD The seventh annual regulatory conference

COMPARABILITYCHALLENGESFORALLOGENEICCELLTHERAPYPRODUCTS

RISKASSESMENTELEMENTS

Experiencegainedduringproductlife

cycle

AffectedstepsoftheManufacturing

process

ImpactofthechangeintheCQA

Protectionofthepatient

Page 7: COMPARABILITY CHALLENGES FOR ALLOGENEIC CELL THERAPY ...€¦ · COMPARABILITY CHALLENGES FOR ALLOGENEIC CELL THERAPY PRODUCTS ÁngelHerrero, PhD The seventh annual regulatory conference

ClinicaltrialInvivostudies

StabilityTesting

ExtendedCharacterisation

InProcessControls

ReleaseTesting

COMPARABILITYCHALLENGESFORALLOGENEICCELLTHERAPYPRODUCTS

Referencematerial?

RISKASSESMENTANALYSES

Page 8: COMPARABILITY CHALLENGES FOR ALLOGENEIC CELL THERAPY ...€¦ · COMPARABILITY CHALLENGES FOR ALLOGENEIC CELL THERAPY PRODUCTS ÁngelHerrero, PhD The seventh annual regulatory conference

COMPARABILITYCHALLENGESFORALLOGENEICCELLTHERAPYPRODUCTS

INTRODUCTIONOFNEWDONATIONS

§ Enoughexperience

§ Updateoftheprotocols

§ Acceptancecriteria

Page 9: COMPARABILITY CHALLENGES FOR ALLOGENEIC CELL THERAPY ...€¦ · COMPARABILITY CHALLENGES FOR ALLOGENEIC CELL THERAPY PRODUCTS ÁngelHerrero, PhD The seventh annual regulatory conference

COMPARABILITYCHALLENGESFORALLOGENEICCELLTHERAPYPRODUCTS

INTRODUCTIONOFNEWDONATIONS

ExperienceDonor

variability

Page 10: COMPARABILITY CHALLENGES FOR ALLOGENEIC CELL THERAPY ...€¦ · COMPARABILITY CHALLENGES FOR ALLOGENEIC CELL THERAPY PRODUCTS ÁngelHerrero, PhD The seventh annual regulatory conference

COMPARABILITYCHALLENGESFORALLOGENEICCELLTHERAPYPRODUCTS

INTRODUCTIONOFNEWDONATIONS

Lowyield

ReleasecriteriaIPCs

Page 11: COMPARABILITY CHALLENGES FOR ALLOGENEIC CELL THERAPY ...€¦ · COMPARABILITY CHALLENGES FOR ALLOGENEIC CELL THERAPY PRODUCTS ÁngelHerrero, PhD The seventh annual regulatory conference

COMPARABILITYCHALLENGESFORALLOGENEICCELLTHERAPYPRODUCTS

Howtoperformacceleratedstabilitytests?

Cancompaniesupdatetheseestablishedcomparabilityprotocolswhengainingexperience?

Howtoestablishabalancewiththeexperienceandthepotentialvariabilityofthedonors?

Arecurrentlyreferencestandardsforcelltherapyproductstobeusedincomparabilitystudies?

Shouldextendedcharacterisation testsneedtobevalidatedinthesamewayasthereleasetestsor

shouldtheysimplybequalified?

Page 12: COMPARABILITY CHALLENGES FOR ALLOGENEIC CELL THERAPY ...€¦ · COMPARABILITY CHALLENGES FOR ALLOGENEIC CELL THERAPY PRODUCTS ÁngelHerrero, PhD The seventh annual regulatory conference

COMPARABILITYCHALLENGESFORALLOGENEICCELLTHERAPYPRODUCTS

Manythanksforyourattention

For any question please [email protected]


Investigation of ALLO-316: A Fratricide-Resistant Allogeneic ......1 Investigation of ALLO -316: A Fratricide-Resistant Allogeneic CAR T Targeting CD70 As a Potential Therapy for the

Investigation of ALLO-316: A Fratricide-Resistant Allogeneic ......1 Investigation of ALLO -316: A Fratricide-Resistant Allogeneic CAR T Targeting CD70 As a Potential Therapy for the

Documents
Transplantation Autologous Syngeneic Allogeneic Xenogeneic

Transplantation Autologous Syngeneic Allogeneic Xenogeneic

Documents
Research Article Allogeneic cell therapy bioprocess ...fatstemserbia.brinkster.net/Library/Medicine... · nologies for downstream processing that are capable of handling this high

Research Article Allogeneic cell therapy bioprocess ...fatstemserbia.brinkster.net/Library/Medicine... · nologies for downstream processing that are capable of handling this high

Documents
Autologous and Allogeneic Cell Therapy Industrialisation – … · 2016. 9. 30. · Autologous and Allogeneic Cell Therapy Industrialisation – Overcoming Clinical ... • Investible

Autologous and Allogeneic Cell Therapy Industrialisation – … · 2016. 9. 30. · Autologous and Allogeneic Cell Therapy Industrialisation – Overcoming Clinical ... • Investible

Documents
For personal use only - ASX · 01 Directors’ Report 10 02 Auditor’s Independence Declaration 21 ... Progenza – allogeneic stem cell therapy technology platform ... conditions

For personal use only - ASX · 01 Directors’ Report 10 02 Auditor’s Independence Declaration 21 ... Progenza – allogeneic stem cell therapy technology platform ... conditions

Documents
Hematopoietic Stem Cell Therapy · PDF fileStored in cellular therapy labs under regulated and monitored temperatures according to ... SUM-WW11_3.ppt Allogeneic Stem Cell Sources by

Hematopoietic Stem Cell Therapy · PDF fileStored in cellular therapy labs under regulated and monitored temperatures according to ... SUM-WW11_3.ppt Allogeneic Stem Cell Sources by

Documents
Cellular Immune Therapy with Allogeneic Stem Cell Transplantation

Cellular Immune Therapy with Allogeneic Stem Cell Transplantation

Documents
Corporate Overview - JefferiesCompany Overview . Developing innovative regenerative therapies . Lead product for orthopedic indications . Based on proprietary allogeneic cell therapy

Corporate Overview - JefferiesCompany Overview . Developing innovative regenerative therapies . Lead product for orthopedic indications . Based on proprietary allogeneic cell therapy

Documents
COST COMPARABILITY HANDBOOK

COST COMPARABILITY HANDBOOK

Documents
Cellular Allogeneic Bone Graft - Home - LifeHealthcare · 2017-06-21 · Cellular Allogeneic Bone Graft . 2. Contents. Page ... allogeneic bone grafts, which contain a reliable source

Cellular Allogeneic Bone Graft - Home - LifeHealthcare · 2017-06-21 · Cellular Allogeneic Bone Graft . 2. Contents. Page ... allogeneic bone grafts, which contain a reliable source

Documents
1 Transplant and Cellular Therapy Unit Institut Paoli Calmettes Inserm U599 Université de la Méditerranée Marseille, France ALLOGENEIC STEM CELL TRANSPLANTATION

1 Transplant and Cellular Therapy Unit Institut Paoli Calmettes Inserm U599 Université de la Méditerranée Marseille, France ALLOGENEIC STEM CELL TRANSPLANTATION

Documents
Autologous and Allogeneic Cell Therapy Industrialisation – Overcoming Clinical Manufacturing Hurdles Early A presentation by Chief Operating Officer, Dr Stephen Ward Nov 2013

Autologous and Allogeneic Cell Therapy Industrialisation – Overcoming Clinical Manufacturing Hurdles Early A presentation by Chief Operating Officer, Dr Stephen Ward Nov 2013

Health & Medicine
Comparability Studies for Autologous Cell Therapy Chris Shen … · 2018. 4. 2. · Comparability Studies for Autologous Cell Therapy Products Chris Shen July, 2017. ... expressions,

Comparability Studies for Autologous Cell Therapy Chris Shen … · 2018. 4. 2. · Comparability Studies for Autologous Cell Therapy Products Chris Shen July, 2017. ... expressions,

Documents
Chapter 5 Comparability Analysis Table of - United Nations€¦ · Chapter 5 Comparability Analysis ... Comparability Analysis in Operation 5 Understanding the economically significant

Chapter 5 Comparability Analysis Table of - United Nations€¦ · Chapter 5 Comparability Analysis ... Comparability Analysis in Operation 5 Understanding the economically significant

Documents
Creating the Shift from Autologous to Allogeneic CAR T Therapy...Therapeutics, Inc. (“Allogene,” “we,” “us,” or “our”), they are forwardlooking statements reflecting

Creating the Shift from Autologous to Allogeneic CAR T Therapy...Therapeutics, Inc. (“Allogene,” “we,” “us,” or “our”), they are forwardlooking statements reflecting

Documents
First-in-Human Study of the Allogeneic Anti-BCMA ALLO-715 CAR … · 2020. 10. 30. · First-in-Human Study of the Allogeneic Anti-BCMA ALLO-715 CAR T cell Therapy and the Anti-CD52

First-in-Human Study of the Allogeneic Anti-BCMA ALLO-715 CAR … · 2020. 10. 30. · First-in-Human Study of the Allogeneic Anti-BCMA ALLO-715 CAR T cell Therapy and the Anti-CD52

Documents
Ranking ≠ Comparability

Ranking ≠ Comparability

Education
Clinical Study Safety of Allogeneic Umbilical Cord Blood Stem Cells Therapy …downloads.hindawi.com/journals/sci/2015/325652.pdf · 2019-07-31 · Clinical Study Safety of Allogeneic

Clinical Study Safety of Allogeneic Umbilical Cord Blood Stem Cells Therapy …downloads.hindawi.com/journals/sci/2015/325652.pdf · 2019-07-31 · Clinical Study Safety of Allogeneic

Documents
Cell Therapy Biomanufacturing: Trends and Perspectives › mws › media › 1675030O › fs... · manufacturing cell-based products at large scale and dealing with both allogeneic

Cell Therapy Biomanufacturing: Trends and Perspectives › mws › media › 1675030O › fs... · manufacturing cell-based products at large scale and dealing with both allogeneic

Documents
Allogeneic Hemopoietic Stem Cell Transplantation .... Allogeneic Hemopoietic Stem Cell...Allogeneic Hemopoietic Stem Cell Transplantation: Transfusion issues Sabita Basu Tata Medical

Allogeneic Hemopoietic Stem Cell Transplantation .... Allogeneic Hemopoietic Stem Cell...Allogeneic Hemopoietic Stem Cell Transplantation: Transfusion issues Sabita Basu Tata Medical

Documents
Chapter 5 Comparability Analysis Table of...2014/09/08  · Comparability Analysis Table of Contents Section # Topic Page 1 Rationale for Comparability Analysis 2 2 Comparability Analysis

Chapter 5 Comparability Analysis Table of...2014/09/08  · Comparability Analysis Table of Contents Section # Topic Page 1 Rationale for Comparability Analysis 2 2 Comparability Analysis

Documents
Allogeneic Cell Therapy Bioprocess Economics and ...discovery.ucl.ac.uk/1402422/1/bit25008.pdf · Allogeneic Cell Therapy Bioprocess Economics and Optimization: Single-Use Cell Expansion

Allogeneic Cell Therapy Bioprocess Economics and ...discovery.ucl.ac.uk/1402422/1/bit25008.pdf · Allogeneic Cell Therapy Bioprocess Economics and Optimization: Single-Use Cell Expansion

Documents
Maximizing Outcomes With Allogeneic HCT in AML: Insight on the Impact of Novel Therapy

Maximizing Outcomes With Allogeneic HCT in AML: Insight on the Impact of Novel Therapy

Health & Medicine
Allogeneic Post Transplant Guide

Allogeneic Post Transplant Guide

Documents
Justfacts...Stem Cell Transplantation and Cellular Therapy University of Utah Stem Cell Transplant and Myeloma Program Adult Autologous and Allogeneic Programs Adult Hematopoietic

Justfacts...Stem Cell Transplantation and Cellular Therapy University of Utah Stem Cell Transplant and Myeloma Program Adult Autologous and Allogeneic Programs Adult Hematopoietic

Documents
Applying Comparability Ratios

Applying Comparability Ratios

Documents
POSTGRADUATE LEUKEMIA CONFERENCE …...viruses) and therapy, which has been, and still is, mainly eradicative, with chemotherapy and bone marrow transplantation, allogeneic and autologous,

POSTGRADUATE LEUKEMIA CONFERENCE …...viruses) and therapy, which has been, and still is, mainly eradicative, with chemotherapy and bone marrow transplantation, allogeneic and autologous,

Documents
Cell Therapy Product Manufacturing Considerations … · –Knowledge of CQA is critical for establishing Product Comparability –Establishing manufacturing control after process

Cell Therapy Product Manufacturing Considerations … · –Knowledge of CQA is critical for establishing Product Comparability –Establishing manufacturing control after process

Documents
Allogeneic Hematopoietic Cell Transplantation for Genetic ...medicalpolicy.bluekc.com/MedPolicyLibrary/Therapy...normal hematopoiesis. Excellent results have been observed with the

Allogeneic Hematopoietic Cell Transplantation for Genetic ...medicalpolicy.bluekc.com/MedPolicyLibrary/Therapy...normal hematopoiesis. Excellent results have been observed with the

Documents
Research Article Allogeneic cell therapy bioprocess economics … · 2017-10-29 · future cience rou 593 Allogeneic cell therapy bioprocess economics: downstream processing decisions

Research Article Allogeneic cell therapy bioprocess economics … · 2017-10-29 · future cience rou 593 Allogeneic cell therapy bioprocess economics: downstream processing decisions

Documents